Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 57851-57900 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT04288427
5-Alpha Reductase 2 as a Marker of Resistance to 5ARI Therapy
NARecruiting
120 participants
Started: Sep 25, 2020 · Completed: Nov 30, 2025
8 conditions2 sponsors1 location
NCT04882904
Continuous Measurement of Activity in Patients with Muscle Pathology and in Control Subjects. ActiSLA Part.
NARecruiting
45 participants
Started: Sep 25, 2020 · Completed: May 31, 2025
1 condition3 sponsors1 location
NCT04571138
A Pediatric and Young Adult Trial of Genetically Modified T Cells Directed Against CD22 for Relapsed/Refractory Leukemia or Lymphoma
PHASE1/PHASE2Recruiting
42 participants
Started: Sep 25, 2020 · Completed: Feb 29, 2040
2 conditions1 sponsor5 locations
NCT04739826
Flumatinib Versus Nilotinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia
N/ARecruiting
491 participants
Started: Sep 25, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03641456
VRD as Induction Followed by VR Maintenance in Patients With Newly Diagnosed High Risk Multiple Myeloma
PHASE2Recruiting
50 participants
Started: Sep 25, 2020 · Completed: Dec 30, 2025
3 conditions1 sponsor1 location
NCT04228367
JuggerStitch Post Market Clinical Follow-up Study
NARecruiting
104 participants
Started: Sep 25, 2020 · Completed: Apr 30, 2026
2 conditions1 sponsor6 locations
NCT04301843
Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma
PHASE2Recruiting
131 participants
Started: Sep 25, 2020 · Completed: Oct 1, 2033
1 condition5 sponsors29 locations
NCT04530227
Camrelizumab With Chemotherapy in Adults With Medically Inoperable Early Stage NSCLC
PHASE2Recruiting
30 participants
Started: Sep 25, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04422652
Combination of Novel Therapies for CKD Comorbid Depression
PHASE2Recruiting
201 participants
Started: Sep 24, 2020 · Completed: Apr 1, 2026
2 conditions2 sponsors4 locations
NCT03975179
Omitting vs. Doing Intraoperative Frozen Section Biopsy for Margin Status in Breast Conserving Surgery
NARecruiting
1,292 participants
Started: Sep 24, 2020 · Completed: Jun 30, 2026
1 condition2 sponsors2 locations
NCT04168502
Gemtuzumab Chemotherapy MRD Levels; Adult Untreated, de Novo, Fav Interm Risk AML
PHASE3Recruiting
414 participants
Started: Sep 24, 2020 · Completed: Apr 30, 2027
1 condition1 sponsor48 locations
NCT04807881
Phase Ib Clinical Study of Keynatinib
PHASE1Recruiting
75 participants
Started: Sep 24, 2020 · Completed: Apr 10, 2028
1 condition1 sponsor4 locations
NCT04562129
IL2 With Ipilimumab Followed by Nivolumab in Stage 3 or 4 Melanoma Patients
PHASE2Recruiting
29 participants
Started: Sep 24, 2020 · Completed: Nov 30, 2029
3 conditions2 sponsors1 location
NCT04260802
A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers
PHASE1/PHASE2Recruiting
116 participants
Started: Sep 24, 2020 · Completed: Sep 30, 2026
19 conditions1 sponsor5 locations
NCT04627376
Multimodal Program for Cancer Related Cachexia Prevention
NARecruiting
60 participants
Started: Sep 24, 2020 · Completed: Jun 30, 2026
5 conditions2 sponsors1 location
NCT04543799
Evaluation of Sleep Quality in Prostate Cancer Patients Undergoing Treatment With Hormonal Therapeutic Approaches and in Patients With Full-resected Early Breast Cancer
N/ARecruiting
60 participants
Started: Sep 24, 2020 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT03846297
Optimisation of Decision Making for Defibrillator Implantation in Hypertrophic Cardiomyopathy
N/ARecruiting
2,000 participants
Started: Sep 23, 2020 · Completed: Mar 31, 2027
1 condition1 sponsor1 location
NCT04573504
Antibiotics for Severe Perineal Laceration to Prevent Infection Following Repair
PHASE4Recruiting
274 participants
Started: Sep 23, 2020 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT04570020
Scleral Lens Fitting Using Wide-Field OCT
N/ARecruiting
258 participants
Started: Sep 23, 2020 · Completed: Dec 31, 2028
2 conditions2 sponsors1 location
NCT04521764
A Vaccine (MV-s-NAP) for the Treatment of Patients With Invasive Metastatic Breast Cancer
PHASE1Recruiting
54 participants
Started: Sep 23, 2020 · Completed: Aug 15, 2027
5 conditions1 sponsor1 location
NCT04578106
Omission of Surgery in Clinically Low-risk HER2positive Breast Cancer With High HER2 Addiction and a Complete Response Following Standard Anti-HER2-based Neoadjuvant Therapy
PHASE2Recruiting
17 participants
Started: Sep 23, 2020 · Completed: Dec 31, 2026
2 conditions3 sponsors1 location
NCT04339764
Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated With Age-Related Macular Degeneration
PHASE1/PHASE2Recruiting
20 participants
Started: Sep 23, 2020 · Completed: May 31, 2029
2 conditions1 sponsor2 locations
NCT05615259
Comparison Between Exactech Guided Personalized Surgery (GPS) and Conventional Instrumentation of Shoulder Arthroplasty
N/ARecruiting
260 participants
Started: Sep 23, 2020 · Completed: Sep 30, 2031
2 conditions1 sponsor1 location
NCT04365205
Effect of Benralizumab on Airway Remodeling in Asthma
N/ARecruiting
60 participants
Started: Sep 23, 2020 · Completed: Oct 5, 2024
1 condition1 sponsor1 location
NCT04390035
BFRT in Adolescents After ACL Reconstruction
NARecruiting
120 participants
Started: Sep 23, 2020 · Completed: Apr 30, 2023
1 condition1 sponsor1 location
NCT04584632
The Efemoral Vascular Scaffold System (EVSS) for the Treatment of Patients with Symptomatic Peripheral Vascular Disease from Stenosis or Occlusion of the Femoropopliteal Artery
NARecruiting
100 participants
Started: Sep 22, 2020 · Completed: Mar 31, 2028
4 conditions1 sponsor4 locations
NCT04060017
Early Treatment of Language Impairment in Young Children With Autism Spectrum Disorder With Leucovorin Calcium
PHASE2Recruiting
80 participants
Started: Sep 22, 2020 · Completed: Jun 30, 2026
2 conditions3 sponsors2 locations
NCT04356755
Subcutaneous Injections of ASC to Heal Digital Ulcers in Patients With Scleroderma.
PHASE2Recruiting
32 participants
Started: Sep 22, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor7 locations
NCT04578301
Predicting Acute-on-Chronic Liver Failure After Surgical Intervention in Chronic Liver Disease
N/ARecruiting
200 participants
Started: Sep 22, 2020 · Completed: Dec 31, 2026
5 conditions1 sponsor1 location
NCT04561557
Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System
EARLY_PHASE1Recruiting
36 participants
Started: Sep 22, 2020 · Completed: May 31, 2027
10 conditions2 sponsors1 location
NCT04339777
Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity
PHASE2Recruiting
66 participants
Started: Sep 22, 2020 · Completed: Nov 30, 2027
5 conditions1 sponsor1 location
NCT04842916
InteGRAtive Analysis of TuMor, Microenvironment, ImmunitY and Patient Expectation for Personalized Response Prediction in Gastric Cancer
N/ARecruiting
250 participants
Started: Sep 22, 2020 · Completed: May 22, 2027
1 condition2 sponsors5 locations
NCT04206319
Radium-223 in Biochemically Recurrent Prostate Cancer
PHASE2Recruiting
26 participants
Started: Sep 22, 2020 · Completed: Nov 15, 2027
1 condition1 sponsor1 location
NCT04539951
Pragmatic Trial of Obsessive-compulsive Disorder
PHASE2Recruiting
1,600 participants
Started: Sep 22, 2020 · Completed: Dec 31, 2028
1 condition13 sponsors1 location
NCT04596813
Role of Cytosorb in Left Ventricular Assist Device Implantation
NARecruiting
60 participants
Started: Sep 21, 2020 · Completed: Jun 30, 2025
1 condition3 sponsors1 location
NCT04447339
Open Nipple Sparing Mastectomy (NSM)
N/ARecruiting
75 participants
Started: Sep 21, 2020 · Completed: Dec 31, 2024
1 condition1 sponsor5 locations
NCT04475666
Replacing Protein Via Enteral Nutrition in Critically Ill Patients
NARecruiting
2,502 participants
Started: Sep 21, 2020 · Completed: Apr 30, 2026
2 conditions1 sponsor2 locations
NCT04298450
ED to EPI: Using SMS to Improve the Transition from the Emergency Department to Early Psychosis Intervention
NARecruiting
186 participants
Started: Sep 21, 2020 · Completed: Dec 31, 2025
11 conditions3 sponsors1 location
NCT04510220
9-month Study to Assess the Efficacy of Ofatumumab on Microglia in Patients With Relapsing Forms of Multiple Sclerosis
PHASE3Recruiting
10 participants
Started: Sep 21, 2020 · Completed: Dec 31, 2021
1 condition2 sponsors1 location
NCT04564391
Whey or Casein - Liver Fat Reduction and Metabolic Improvement by Fast vs. Slow Proteins
NARecruiting
80 participants
Started: Sep 21, 2020 · Completed: Jun 30, 2025
2 conditions4 sponsors1 location
NCT04615221
Immunological Mechanisms of Rejection in Uterine Transplantation
NARecruiting
30 participants
Started: Sep 21, 2020 · Completed: Sep 30, 2033
1 condition1 sponsor1 location
NCT04558450
Covid-19 Effects on Arterial Stiffness and Vascular Aging (CARTESIAN)
NARecruiting
360 participants
Started: Sep 21, 2020 · Completed: Mar 31, 2033
4 conditions3 sponsors3 locations
NCT04166331
Adjunctive DobutAmine in sePtic Cardiomyopathy With Tissue Hypoperfusion
PHASE3Recruiting
270 participants
Started: Sep 20, 2020 · Completed: Dec 20, 2025
4 conditions2 sponsors27 locations
NCT06844942
Vessel Imaging Using Optical Coherence Tomography for Plaque Morphology and Vessel Fractional Flow Reserve
N/ARecruiting
200 participants
Started: Sep 20, 2020 · Completed: Jan 31, 2029
4 conditions1 sponsor1 location
NCT04606732
CardioVascular Disease Progression and Prognosis in COVID-19
N/ARecruiting
2,000 participants
Started: Sep 20, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04555577
Peposertib and Radiation Therapy, Followed by Temozolomide for the Treatment of Patients With Newly Diagnosed MGMT Unmethylated Glioblastoma or Gliosarcoma
PHASE1Recruiting
29 participants
Started: Sep 20, 2020 · Completed: Oct 30, 2025
2 conditions2 sponsors1 location
NCT05277857
Mycobacterial Lung Diseases in Virginia: Sequencing and Clinical Determinants of Relapse and Outcome
N/ARecruiting
720 participants
Started: Sep 20, 2020 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06379152
Effect of Bilirubin on Prognosis in Heart Failure With Preserved Ejection Fraction
N/ARecruiting
400 participants
Started: Sep 20, 2020 · Completed: Jul 1, 2024
2 conditions1 sponsor1 location
NCT06691880
Feasibility of Video Gaming Technology for Arm Recovery Early Post-stroke
NARecruiting
60 participants
Started: Sep 20, 2020 · Completed: Mar 20, 2026
2 conditions1 sponsor1 location
NCT04576143
Efficacy and Safety of Dose-dense Chemotherapy (ddEC-ddP) for Neoadjuvant Chemotherapy of HER2-negative Breast Cancer
PHASE2/PHASE3Recruiting
260 participants
Started: Sep 20, 2020 · Completed: Sep 20, 2027
2 conditions6 sponsors1 location